Forte Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Forte Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q3 2024.
  • Forte Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.63M, a 15.5% increase year-over-year.
  • Forte Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$35.6M, a 14.8% decline year-over-year.
  • Forte Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$32.5M, a 134% decline from 2022.
  • Forte Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$13.9M, a 35.3% increase from 2021.
  • Forte Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$21.5M, a 53.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$35.6M -$8.63M +$1.59M +15.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$37.2M -$12.8M -$3.78M -41.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$33.4M -$7.8M -$949K -13.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$32.5M -$6.38M -$1.44M -29.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$31M -$10.2M -$6.79M -198% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$24.3M -$9.03M -$6.01M -199% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$18.2M -$6.86M -$4.34M -173% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$13.9M -$4.94M -$1.64M -49.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$12.3M -$3.42M +$4.28M +55.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$16.5M -$3.02M +$2.73M +47.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$19.3M -$2.51M +$2.23M +47% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$21.5M -$3.3M +$1.19M +26.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$22.7M -$7.7M -$2.69M -53.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$20M -$5.75M +$29M +83.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$49M -$4.74M -$2.71M -134% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$46.3M -$4.49M -$18.6M -132% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$27.7M -$5.01M -$4.32M -632% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$23.3M -$34.8M -$34.1M -5425% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $10.8M -$2.03M +$14.8M +88% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$4.06M $14.1M +$33.2M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$37.3M -$684K -$2.11M -148% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$35.2M -$629K +$14.7M +95.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$49.9M -$16.9M -$4.03M -31.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 -$45.9M -$19.1M -$8.42M -78.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$37.4M $1.43M +$11.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$48.6M -$15.3M -$6.68M -77.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$41.9M -$12.8M -$4.29M -50.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$37.6M -$10.7M -$2.71M -34% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$34.9M -$9.74M -$1.21M -14.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$33.7M -$8.65M -$1.03M -13.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$32.7M -$8.55M -$987K -13% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$31.7M -$7.97M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$8.53M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$7.62M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$7.57M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.